目录肽产品
MART-002B
MART-1 (27-35) (human)
H-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH\nAcetate salt
H-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH\nAcetate salt
Size：5
P1(RMB)：1050
MW：813.99
One letter sequence：AAGIGILTV
Molecular Formula：C37H67N9O11
Description：Melan A corresponds to residues 27-35 of the nonmutated melanoma-associated antigen MART-1/Melan A. The sequence AAGIGILTV is the immunodominant epitope recognized by most melanoma-specific, HLA-A*0201-restricted, cytotoxic T lymphocytes (CTL).
Literature Reference：A.van Elsas et al., Eur. J. Immunol., 26, 1683 (1996)\nM.J.M?urer et al., Eur. J. Immunol., 26, 2613 (1996)\nJ.N.Cormier et al., Cancer J. Sci. Am., 3, 37 (1997)\nF.O.Nestle et al., Nat. Med., 4, 328 (1998)\nM.P.Velders et al., Crit. Rev. Immunol., 18, 7 (1998)
Cas：156251-11-5
P1(RMB)：1050
MW：813.99
One letter sequence：AAGIGILTV
Molecular Formula：C37H67N9O11
Description：Melan A corresponds to residues 27-35 of the nonmutated melanoma-associated antigen MART-1/Melan A. The sequence AAGIGILTV is the immunodominant epitope recognized by most melanoma-specific, HLA-A*0201-restricted, cytotoxic T lymphocytes (CTL).
Literature Reference：A.van Elsas et al., Eur. J. Immunol., 26, 1683 (1996)\nM.J.M?urer et al., Eur. J. Immunol., 26, 2613 (1996)\nJ.N.Cormier et al., Cancer J. Sci. Am., 3, 37 (1997)\nF.O.Nestle et al., Nat. Med., 4, 328 (1998)\nM.P.Velders et al., Crit. Rev. Immunol., 18, 7 (1998)
Cas：156251-11-5
